An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS)
Crossref DOI link: https://doi.org/10.1186/s12979-021-00225-0
Published Online: 2021-04-14
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bolton, Christopher https://orcid.org/0000-0003-2382-8209
Text and Data Mining valid from 2021-04-14
Version of Record valid from 2021-04-14
Article History
Received: 18 July 2020
Accepted: 12 March 2021
First Online: 14 April 2021
Declarations
:
: Not required
: Not applicable.
: The author declares no conflicts of interest.